Advertisement
Australia markets closed
  • ALL ORDS

    8,015.80
    +72.20 (+0.91%)
     
  • AUD/USD

    0.6642
    +0.0029 (+0.44%)
     
  • ASX 200

    7,778.10
    +77.80 (+1.01%)
     
  • OIL

    80.41
    +0.08 (+0.10%)
     
  • GOLD

    2,332.60
    +3.60 (+0.15%)
     
  • Bitcoin AUD

    97,737.41
    -693.12 (-0.70%)
     
  • CMC Crypto 200

    1,347.22
    -42.18 (-3.03%)
     

Phreesia First Quarter 2025 Earnings: EPS Beats Expectations

Phreesia (NYSE:PHR) First Quarter 2025 Results

Key Financial Results

  • Revenue: US$101.2m (up 21% from 1Q 2024).

  • Net loss: US$19.7m (loss narrowed by 48% from 1Q 2024).

  • US$0.35 loss per share (improved from US$0.70 loss in 1Q 2024).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Phreesia EPS Beats Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 30%.

Looking ahead, revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare Services industry in the US.

ADVERTISEMENT

Performance of the American Healthcare Services industry.

The company's shares are down 18% from a week ago.

Risk Analysis

You still need to take note of risks, for example - Phreesia has 4 warning signs (and 1 which makes us a bit uncomfortable) we think you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.